USD 5.99
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 4.15 Million EUR | -65.02% |
2022 | 11.89 Million EUR | 1485.78% |
2021 | -858 Thousand EUR | 83.15% |
2020 | -5.09 Million EUR | -180.45% |
2019 | -1.81 Million EUR | -1125.99% |
2018 | 177 Thousand EUR | -95.56% |
2017 | 3.98 Million EUR | 694.93% |
2016 | -670 Thousand EUR | -194.77% |
2015 | 707 Thousand EUR | 120.32% |
2014 | -3.47 Million EUR | -35.0% |
2013 | -2.57 Million EUR | -89.9% |
2012 | -1.35 Million EUR | -958.86% |
2011 | 158 Thousand EUR | 18.8% |
2010 | 133 Thousand EUR | 103.68% |
2009 | -3.61 Million EUR | 23.88% |
2008 | -4.74 Million EUR | 51.81% |
2007 | -9.85 Million EUR | -442.98% |
2006 | -1.81 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 3 Million EUR | -27.7% |
2024 Q2 | 3.37 Million EUR | 12.11% |
2023 Q2 | 13.41 Million EUR | 9.01% |
2023 FY | 4.15 Million EUR | -65.02% |
2023 Q3 | 14.05 Million EUR | 4.78% |
2023 Q1 | 12.3 Million EUR | 3.52% |
2023 Q4 | 4.15 Million EUR | -70.42% |
2022 Q3 | 9.64 Million EUR | 78.15% |
2022 Q4 | 11.89 Million EUR | 23.28% |
2022 FY | 11.89 Million EUR | 1485.78% |
2022 Q1 | 389 Thousand EUR | 145.34% |
2022 Q2 | 5.41 Million EUR | 1291.77% |
2021 FY | -858 Thousand EUR | 83.15% |
2021 Q1 | -5.87 Million EUR | -15.28% |
2021 Q2 | -6.19 Million EUR | -5.52% |
2021 Q3 | -5.65 Million EUR | 8.67% |
2021 Q4 | -858 Thousand EUR | 84.84% |
2020 FY | -5.09 Million EUR | -180.45% |
2020 Q2 | -3.68 Million EUR | -56.6% |
2020 Q3 | -4.76 Million EUR | -29.18% |
2020 Q4 | -5.09 Million EUR | -6.91% |
2020 Q1 | -2.35 Million EUR | -29.68% |
2019 Q2 | 716 Thousand EUR | -31.42% |
2019 Q3 | -1.23 Million EUR | -272.35% |
2019 Q4 | -1.81 Million EUR | -47.16% |
2019 FY | -1.81 Million EUR | -1125.99% |
2019 Q1 | 1.04 Million EUR | 489.83% |
2018 Q1 | 4.89 Million EUR | 22.75% |
2018 Q4 | 177 Thousand EUR | -86.34% |
2018 Q3 | 1.29 Million EUR | -74.31% |
2018 Q2 | 5.04 Million EUR | 3.11% |
2018 FY | 177 Thousand EUR | -95.56% |
2017 Q2 | 4.29 Million EUR | 990.66% |
2017 Q3 | -913 Thousand EUR | -121.27% |
2017 FY | 3.98 Million EUR | 694.93% |
2017 Q4 | 3.98 Million EUR | 536.58% |
2017 Q1 | -482 Thousand EUR | 28.06% |
2016 FY | -670 Thousand EUR | -194.77% |
2016 Q4 | -670 Thousand EUR | -291.81% |
2016 Q3 | -171 Thousand EUR | -116.27% |
2016 Q2 | 1.05 Million EUR | 2.24% |
2016 Q1 | 1.02 Million EUR | 45.4% |
2015 FY | 707 Thousand EUR | 120.32% |
2015 Q4 | 707 Thousand EUR | 250.75% |
2015 Q2 | -1.08 Million EUR | 74.71% |
2015 Q3 | -469 Thousand EUR | 56.65% |
2015 Q1 | -4.27 Million EUR | -23.0% |
2014 Q1 | -3.05 Million EUR | -18.47% |
2014 Q4 | -3.47 Million EUR | 16.63% |
2014 FY | -3.47 Million EUR | -35.0% |
2014 Q3 | -4.17 Million EUR | -38.91% |
2014 Q2 | -3 Million EUR | 1.6% |
2013 Q3 | -2.06 Million EUR | -32.22% |
2013 FY | -2.57 Million EUR | -89.9% |
2013 Q4 | -2.57 Million EUR | -24.85% |
2013 Q2 | -1.56 Million EUR | -15.29% |
2013 Q1 | -1.35 Million EUR | 0.22% |
2012 Q4 | -1.35 Million EUR | -45.6% |
2012 Q1 | 101 Thousand EUR | -36.08% |
2012 Q2 | -142 Thousand EUR | -240.59% |
2012 Q3 | -932 Thousand EUR | -556.34% |
2012 FY | -1.35 Million EUR | -958.86% |
2011 Q1 | 1.25 Million EUR | 841.35% |
2011 FY | 158 Thousand EUR | 18.8% |
2011 Q2 | 990 Thousand EUR | -20.93% |
2011 Q3 | -522 Thousand EUR | -152.73% |
2011 Q4 | 158 Thousand EUR | 130.27% |
2010 FY | 133 Thousand EUR | 103.68% |
2010 Q4 | 133 Thousand EUR | -89.44% |
2010 Q3 | 1.25 Million EUR | -10.39% |
2010 Q2 | 1.4 Million EUR | 138.25% |
2010 Q1 | -3.67 Million EUR | -1.6% |
2009 Q4 | -3.61 Million EUR | 0.0% |
2009 Q2 | -3.01 Million EUR | 0.0% |
2009 FY | -3.61 Million EUR | 23.88% |
2008 FY | -4.74 Million EUR | 51.81% |
2007 FY | -9.85 Million EUR | -442.98% |
2006 FY | -1.81 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
The Amacore Group, Inc. | -469.62 Thousand USD | 985.595% |
Arem Pacific Corporation | 181.02 Thousand USD | -2197.498% |
Assisted 4 Living, Inc. | -199.71 Thousand USD | 2182.499% |
BioCorRx Inc. | 5.56 Million USD | 25.326% |
Bionik Laboratories Corp. | 1.98 Million USD | -109.529% |
Banyan Corp. | 3.6 Million USD | -15.317% |
Clearday, Inc. | 44.86 Million USD | 90.731% |
Dental Patient Care America, Inc. | -1.99 Million USD | 308.263% |
Quantum Medical Transport, Inc. | 1065.27 USD | -390317.453% |
Empower Clinics Inc. | 2.29 Million USD | -80.917% |
First Choice Healthcare Solutions, Inc. | 23.22 Million USD | 82.096% |
Selectis Health, Inc. | 35.76 Million USD | 88.37% |
Ethema Health Corporation | 14.51 Million USD | 71.346% |
HealthLynked Corp. | 1.72 Million USD | -140.889% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | 13.79 Million USD | 69.848% |
JRSIS Health Care Corporation | 911.83 Thousand USD | -356.114% |
Comjoyful International Company | -28.32 Thousand USD | 14781.069% |
Medical Facilities Corporation | 92.22 Million USD | 95.49% |
MedSmart Group Inc. | 659.56 Thousand USD | -530.571% |
North America Frac Sand, Inc. | 265.41 Thousand USD | -1466.98% |
Nova Leap Health Corp. | -686.52 Thousand USD | 705.804% |
Nexteligent Holdings, Inc. | 1.83 Million USD | -126.247% |
PAO Group, Inc. | 639.37 Thousand USD | -550.479% |
Primemd Inc. | 4.54 Million USD | 8.465% |
Raffles Medical Group Ltd | -194.49 Million USD | 102.138% |
Ryman Healthcare Limited | 1.51 Billion USD | 99.725% |
Stem Cell Authority, Ltd. | 15.00 USD | -27726566.667% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | 1.24 Million USD | -234.561% |
Mycotopia Therapies, Inc. | 811.51 Thousand USD | -412.497% |
U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 1191.601% |
Veltex Corporation | 2.17 Million USD | -90.831% |
World Financial Holding Group | 98.11 Thousand USD | -4138.99% |
Xcelerate Inc. | 1.18 Million USD | -251.634% |